By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical steroids > Fluocinolone topical oil > Fluocinolone Topical Dosage
Topical steroids
https://themeditary.com/dosage-information/fluocinolone-topical-dosage-11286.html

Fluocinolone Topical Dosage

Drug Detail:Fluocinolone topical oil (Fluocinolone topical oil [ floo-oh-sin-oh-lone-top-i-kal ])

Drug Class: Topical steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Seborrheic Dermatitis

No more than one ounce of the shampoo should be applied to the scalp area once a day, worked into a lather and allowed to remain on the scalp for approximately 5 minutes

Comments:

  • Hair and scalp should be rinsed thoroughly with water.

Use: Treatment of seborrheic dermatitis of the scalp

Usual Adult Dose for Psoriasis

Apply a thin film on the scalp, massage well and cover scalp with the supplied shower cap.

Comments:

  • Wet or dampen hair and scalp thoroughly
  • Leave the oil on overnight or for a minimum of 4 hours before washing it off
  • Wash hair with regular shampoo and rinse thoroughly

Use: Treatment of psoriasis of the scalp

Usual Adult Dose for Dermatitis

Apply a thin film to the affected area two to four times a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
  • If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Apply a thin film to the affected area two to four times a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
  • If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Atopic Dermatitis

Topical (body) oil: Apply a thin film to the affected areas three times a day

Comments:

  • Use should be discontinued when control of disease is achieved.
  • If no improvement is seen within 2 weeks, a healthcare provider should be contacted.

Use: Treatment of atopic dermatitis

Usual Pediatric Dose for Atopic Dermatitis

3 months and older:
Topical (scalp and body) oil: Apply to affected area twice a day for up to 4 weeks

Comments:

  • The oil should not be applied to the diaper area.
  • Intertriginous areas should be avoided.
  • Safety and effectiveness in pediatric patients younger than 3 months of age have not been established.

Use: Treatment of moderate to severe atopic dermatitis

Usual Pediatric Dose for Seborrheic Dermatitis

No more than one ounce of the shampoo should be applied to the scalp area once a day, worked into a lather and allowed to remain on the scalp for approximately 5 minutes

Comments:

  • Safety and effectiveness in children and infants have not been established.
  • Hair and scalp should be rinsed thoroughly with water.

Use: Treatment of seborrheic dermatitis of the scalp

Usual Pediatric Dose for Dermatitis

Apply a thin film to the affected area two to four times a day

Comments:

  • Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.
  • Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
  • If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

Apply a thin film to the affected area two to four times a day

Comments:

  • Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.
  • Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
  • If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy in pediatric patients younger than 3 months of age have not been established.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • This drug should not be used on the face, groin, or axillae, unless directed by a healthcare professional.
  • The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
  • Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Storage requirements:
  • Excessive heat and freezing should be avoided.

Monitoring:
  • Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
  • Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
  • This medication is to be used as directed by the physician. It is for external use only. Contact with the eyes should be avoided.
  • Patients should be advised not to use this medication for any condition other than for which it was prescribed.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by